Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro

Olaso, 1998, Molecular regulation of hepatic fibrogenesis, J Hepatol, 29, 836, 10.1016/S0168-8278(98)80269-9

Rojkind, 1979, Collagen types in normal and cirrhotic liver, Gastroenterology, 76, 710, 10.1016/S0016-5085(79)80170-5

Milani, 1989, In situ hybridization for procollagen type I, III, and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells, Hepatology, 10, 84, 10.1002/hep.1840100117

Friedman, 1993, The cellular basis of hepatic fibrosis, N Engl J Med, 328, 1828, 10.1056/NEJM199306243282508

Maher, 1990, Extracellular matrix gene expression increases preferentially in rat lymphocytes and sinusoidal endothelial cells during hepatic fibrogenesis in vivo, J Clin Invest, 86, 1641, 10.1172/JCI114886

Blomhoff, 1991, Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis, FASEB J, 5, 271, 10.1096/fasebj.5.3.2001786

Bissel, 1992, Lipocyte activation and hepatic fibrosis, Gastroenterology, 102, 1803, 10.1016/0016-5085(92)91747-R

Friedman, 1989, Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix, J Biol Chem, 264, 10756, 10.1016/S0021-9258(18)81686-6

Eng, 2000, New insights into hepatic stellate cells activation: the simple becomes complex, Am J Physiol, 279, G7

Pinzani, 1988, Signal transduction in hepatic stellate cells, Liver, 18, 2, 10.1111/j.1600-0676.1998.tb00120.x

Kliewer, 1994, Differential expression and activation of a family of murine peroxisome proliferator-activated receptors, Proc Natl Acad Sci U S A, 91, 7355, 10.1073/pnas.91.15.7355

Tontonoz, 1995, Regulation of adipocyte gene expression and differentiation by peroxisome proliferator-activated receptor gamma, Curr Opin Gene Dev, 5, 571, 10.1016/0959-437X(95)80025-5

Kliewer, 1992, Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathway through heterodimer formation of their receptors, Nature, 358, 771, 10.1038/358771a0

Forman, 1995, 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma, Cell, 83, 803, 10.1016/0092-8674(95)90193-0

Rocchi, 1999, Peroxisome proliferator-activated receptor-γ: a versatile metabolic regulator, Ann Med, 31, 342, 10.3109/07853899908995901

Everett, 2000, The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease, Liver, 20, 191, 10.1034/j.1600-0676.2000.020003191.x

Galli, 2000, Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation in human hepatic stellate cells, Hepatology, 31, 101, 10.1002/hep.510310117

Marra, 2000, Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells, Gastroenterology, 110, 466, 10.1053/gast.2000.9365

Lehman, 1995, An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ, J Biol Chem, 270, 12953, 10.1074/jbc.270.22.12953

Young, 1998, Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor γ, J Pharmacol Exp Ther, 284, 751

Lefebvre, 1997, Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates, Arterioscler Thromb Vasc Biol, 17, 1756, 10.1161/01.ATV.17.9.1756

Schwartz, 1998, Effect of troglitazone in insulin-treated patients with type 2 diabetes mellitus, New Engl J Med, 338, 861, 10.1056/NEJM199803263381302

Peraldi, 1997, Thiazolidinediones block tumor necrosis factor α-induced inhibition of insulin signaling, J Clin Invest, 100, 1863, 10.1172/JCI119715

Spiegelman, 1998, PPARγ: adipogenic regulator and thiazolidinedione receptor, Diabetes, 47, 507, 10.2337/diabetes.47.4.507

Willson, 1996, The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonist and the antihyperglicemic activity of thiazolidinediones, J Med Chem, 39, 665, 10.1021/jm950395a

Berger, 1996, Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice, Endocrinology, 137, 4189, 10.1210/endo.137.10.8828476

Svegliati-Baroni, 1996, Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis, Hepatology, 23, 1189, 10.1002/hep.510230538

Frizell, 1994, FK506 enhanced fibrogenesis in vitro and in vivo models of liver fibrosis, Gastroenterology, 107, 492, 10.1016/0016-5085(94)90176-7

Ishak, 1995, Histological grading and staging of chronic hepatitis, J Hepatol, 22, 696, 10.1016/0168-8278(95)80226-6

Svegliati-Baroni, 1999, Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C, Liver, 19, 212, 10.1111/j.1478-3231.1999.tb00038.x

Mancini, 1994, Immunohistochemical analysis of S-phase cells in normal human and rat liver by PC10 monoclonal antibody, Liver, 14, 57, 10.1111/j.1600-0676.1994.tb00048.x

Knook, 1982, Fat storing cells of the liver, Exp Cell Res, 139, 468, 10.1016/0014-4827(82)90283-X

Casini, 1991, Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism, Hepatology, 13, 758

Casini, 1993, Regulation of extracellular matrix synthesis by transforming growth factor β1 in human fat-storing cells, Gastroenterology, 105, 245, 10.1016/0016-5085(93)90033-9

Andrews, 1991, A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells, Nucl Acids Res, 19, 2499, 10.1093/nar/19.9.2499

Tontonoz, 1994, mPPARγ2: tissue-specific regulator of an adipocyte enhancer, Genes Dev, 8, 1224, 10.1101/gad.8.10.1224

Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2

Basset, 1990, A novel metalloproteinase gene specially expressed in stromal cells of breast carcinoma, Nature, 348, 699, 10.1038/348699a0

Boast, 1990, Functional analysis of cis-acting DNA sequences controlling transcription of human type I collagen genes, J Biol Chem, 265, 13351, 10.1016/S0021-9258(19)38305-X

de Wet, 1987, Firefly luciferase gene: structure and expression in mammalian cells, Mol Cell Biol, 7, 725, 10.1128/MCB.7.2.725

Crabb, 1987, A method of increasing the sensitivity of chloramphenicol acetyltransferase assay in extracts of transfected cultured cells, Anal Biochem, 163, 88, 10.1016/0003-2697(87)90096-0

1999

Benedetti, 2001, inhibition of Na+/K+ exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study, Gastroenterology, 120, 545, 10.1053/gast.2001.21203

Galli, 1998, High level expression of RXRα and the presence of endogenous ligands contribute to expression of a peroxisomal proliferator receptor-responsive gene in hepatoma cells, Arch Biochem Biophys, 354, 288, 10.1006/abbi.1997.0701

Ibrahimi, 1994, Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells, Mol Pharmacol, 46, 1070

Forman, 1997, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptor α and δ, Proc Natl Acad Sci U S A, 94, 4312, 10.1073/pnas.94.9.4312

Chawla, 2001, PPARγ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation, Nat Med, 7, 48, 10.1038/83336

Wright, 2000, A synthetic antagonist for the peroxisome proliferator-activated receptor γ inhibits adipocyte differentiation, J Biol Chem, 275, 1873, 10.1074/jbc.275.3.1873

Saltier, 1996, Thiazolidinediones in treatment of insulin resistance and type II diabetes, Diabetes, 45, 1661, 10.2337/diab.45.12.1661

Burant, 1997, Troglitazone action is independent of adipose tissue, J Clin Invest, 100, 2900, 10.1172/JCI119839

Olefky, 2000, Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists, J Clin Invest, 106, 467, 10.1172/JCI10843

Barman Balfaur, 1999, Rosiglitazone, Drugs, 57, 921, 10.2165/00003495-199957060-00007

Plosker, 1999, Troglitazone: a review of its use in the management of type 2 diabetes mellitus, Drugs, 57, 409, 10.2165/00003495-199957030-00014

Lawrence, 2000, Pioglitazone, Int J Clin Pract, 54, 614, 10.1111/j.1742-1241.2000.tb10937.x

Green, 1999, Rosiglitazone: a new therapy for type 2 diabetes, Expert Opin Invest Drugs, 8, 1709, 10.1517/13543784.8.10.1709

Miyahara, 2000, Peroxisome proliferator-activated receptors and hepatic stellate cells activation, J Biol Chem, 275, 35715, 10.1074/jbc.M006577200

Marra, 1999, Hepatic stellate cells and the regulation of liver inflammation, J Hepatol, 31, 1120, 10.1016/S0168-8278(99)80327-4

Murphy, 2000, PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer, Trends Pharmacol Sci, 21, 469, 10.1016/S0165-6147(00)01559-5

Ricote, 1998, The peroxisome proliferator-γ is a negative regulator of macrophage activation, Nature, 391, 79, 10.1038/34178

Su, 1999, A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response, J Clin Invest, 104, 383, 10.1172/JCI7145

Pershadsingh, 1998, Treatment of psoriasis with troglitazone therapy, Arch Dermatol, 134, 1304, 10.1001/archderm.134.10.1304

Hines, 1993, In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury, Am J Pathol, 142, 511

Uchimura, 2000, Activation of retinoic X receptor and peroxisome proliferator-activated receptor-γ inhibits nitric oxide and tumor necrosis factor-α production in rat Kupffer cells, Hepatology, 33, 91, 10.1053/jhep.2001.21145

Marra, 1998, Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration, Am J Pathol, 152, 423

Tanaka, 1999, Down regulation of peroxisome proliferator-activated receptor γ expression by inflammatory cytokines and its reversal by thiazolidinediones, Diabetologia, 42, 702, 10.1007/s001250051218

Palakurthi, 2001, Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor γ and mediated by inhibition of translation initiation, Cancer Res, 61, 6213

Bellingham, 1992, Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of glucocorticoid responsiveness, Mol Endocrinol, 6, 2090

Engel, 1998, Signal transduction by transforming growth factor β: a cooperative paradigm with extensive negative regulation, J Cell Biochem, 30-31, 111, 10.1002/(SICI)1097-4644(1998)72:30/31+<111::AID-JCB15>3.0.CO;2-5

Weiner, 1990, Ito-cell gene expression and collagen regulation, Hepatology, 11, 111, 10.1002/hep.1840110119

Adams, 1997, Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at the consensus mitogen-activated protein kinase site, J Biol Chem, 272, 5128, 10.1074/jbc.272.8.5128

Han, 1999, Transforming growth factor-β1 (TGF-β1) and TGF-β2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-γ, J Biol Chem, 2, 1241

Inagaki, 1995, Overlapping pathways mediate the opposing action of tumor necrosis factor-α and transforming growth factor-β on α2(I) collagen gene transcription, J Biol Chem, 270, 3353, 10.1074/jbc.270.7.3353

Chung, 1996, An AP-1 binding sequence is essential for regulation of the human α2(I) collagen (COL1A2) promoter activity by transforming growth factor-β, J Biol Chem, 271, 3272, 10.1074/jbc.271.6.3272

Jiang, 1998, PPARγ agonists inhibit production of monocyte inflammatory cytokines, Nature, 391, 82, 10.1038/35154

Galli, 2001, The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor α is inhibited by ethanol metabolism, J Biol Chem, 276, 68, 10.1074/jbc.M008791200